Allergy Therapeutics plc's "Buy" Rating Reiterated at Panmure Gordon

‘s stock had its “buy” rating reissued by analysts at Panmure Gordon in a research report issued to clients and investors on Monday, Marketbeat reports. They presently have a GBX 47 price objective on the stock.